WEIGHT-LOSS IN A MURINE CACHEXIA MODEL IS NOT ASSOCIATED WITH THE CYTOKINES TUMOR-NECROSIS-FACTOR-ALPHA OR INTERLEUKIN-6

被引:22
作者
MULLIGAN, HD
MAHONY, SM
ROSS, JA
TISDALE, MJ
机构
[1] UNIV ASTON,INST PHARMACEUT SCI,CRC EXPTL CHEMOTHERAPY GRP,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND
[2] UNIV EDINBURGH,ROYAL INFIRM EDINBURGH,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
关键词
CACHEXIA; TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; ANTI-TNF-ALPHA ANTIBODIES;
D O I
10.1016/0304-3835(92)90238-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Daily administration of an escalating dose of tumour necrosis factor-alpha (TNF-alpha) to female NMRI mice caused a progressive loss of body weight representing 12% of the original weight over a 6-day period. Weight loss was associated with a decreased food intake and pair-fed controls exhibited a weight loss of similar magnitude to that caused by TNF-alpha. However, weight loss in animals bearing a murine adenocarcinoma (MAC16) occurred without a change in energy intake and thus differed from that produced by TNF-alpha. Anti-TNF-alpha monoclonal antibodies at levels capable of protecting mice against lethal endotoxaemia were ineffective in reversing weight loss in animals bearing the MAC16 tumour and had no effect on the increase in tumour volume. Circulating levels of interleukin-6 were not elevated in animals bearing the MAC16 tumour and with a weight loss between 1.8 and 5.4 g. These results suggest that these cytokines are not involved in the cachexia produced by this murine tumour.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 21 条
[11]  
MAHONY SM, 1988, BRIT J CANCER, V58, P233
[12]   METABOLIC SUBSTRATE UTILIZATION BY TUMOR AND HOST TISSUES IN CANCER CACHEXIA [J].
MULLIGAN, HD ;
TISDALE, MJ .
BIOCHEMICAL JOURNAL, 1991, 277 :321-326
[13]   TUMORS SECRETING HUMAN TNF CACHECTIN INDUCE CACHEXIA IN MICE [J].
OLIFF, A ;
DEFEOJONES, D ;
BOYER, M ;
MARTINEZ, D ;
KIEFER, D ;
VUOCOLO, G ;
WOLFE, A ;
SOCHER, SH .
CELL, 1987, 50 (04) :555-563
[14]   COMPARISON OF SERUM AMYLOID-A PROTEIN AND C-REACTIVE PROTEIN CONCENTRATIONS IN CANCER AND NONMALIGNANT DISEASE [J].
RAYNES, JG ;
COOPER, EH .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (07) :798-803
[15]   TUMOR NECROSIS FACTOR IN MAN - CLINICAL AND BIOLOGICAL OBSERVATIONS [J].
SELBY, P ;
HOBBS, S ;
VINER, C ;
JACKSON, E ;
JONES, A ;
NEWELL, D ;
CALVERT, AH ;
MCELWAIN, T ;
FEARON, K ;
HUMPHREYS, J ;
SHIGA, T .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :803-808
[16]   ANTICACHECTIN TUMOR NECROSIS FACTOR-ALPHA ANTIBODIES ATTENUATE DEVELOPMENT OF CACHEXIA IN TUMOR-MODELS [J].
SHERRY, BA ;
GELIN, J ;
FONG, Y ;
MARANO, M ;
WEI, H ;
CERAMI, A ;
LOWRY, SF ;
LUNDHOLM, KG ;
MOLDAWER, LL .
FASEB JOURNAL, 1989, 3 (08) :1956-1962
[17]   TUMOR NECROSIS FACTOR NOT DETECTABLE IN PATIENTS WITH CLINICAL CANCER CACHEXIA [J].
SOCHER, SH ;
MARTINEZ, D ;
CRAIG, JB ;
KUHN, JG ;
OLIFF, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (08) :595-598
[18]   LONG-TERM INHIBITION OF TUMOR-GROWTH BY TUMOR-NECROSIS-FACTOR IN THE ABSENCE OF CACHEXIA OR T-CELL IMMUNITY [J].
TENG, MN ;
PARK, BH ;
KOEPPEN, HKW ;
TRACEY, KJ ;
FENDLY, BM ;
SCHREIBER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3535-3539
[19]   INHIBITION OF TUMOR-INDUCED LIPOLYSIS INVITRO AND CACHEXIA AND TUMOR-GROWTH INVIVO BY EICOSAPENTAENOIC ACID [J].
TISDALE, MJ ;
BECK, SA .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (01) :103-107
[20]   METABOLIC EFFECTS OF CACHECTIN TUMOR-NECROSIS-FACTOR ARE MODIFIED BY SITE OF PRODUCTION - CACHECTIN TUMOR NECROSIS FACTOR-SECRETING TUMOR IN SKELETAL-MUSCLE INDUCES CHRONIC CACHEXIA, WHILE IMPLANTATION IN BRAIN INDUCES PREDOMINATELY ACUTE ANOREXIA [J].
TRACEY, KJ ;
MORGELLO, S ;
KOPLIN, B ;
FAHEY, TJ ;
FOX, J ;
ALEDO, A ;
MANOGUE, KR ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :2014-2024